VivaMed partners with medical research universities worldwide to take drug assets from late preclinical development to clinical proof of concept by leveraging strategic partnerships with research scientists, clinicians, CRO's, manufacturers, and scaled life sciences companies. We focus on developing therapeutics for chronic conditions that are resistant to conventional standards of care, such as CNS, Rare Disease, Metabolic, Cardiopulmonary, and Cerebrovascular disorders.
| Website | http://www.vivamed.com |
| Employees | 26 (14 on RocketReach) |
| Founded | 2003 |
| Address | 57 W 57th Street 3rd Floor, New York, New York 10019, US |
| Industry | Biotechnology |
| Keywords | Drug Development, Drug Discovery, Pharmaceutical Development, Preclinical Research, Clinical Research, Pharmaceutical Research, Clinical Trials, Proof Of Concept, Research Partnerships, Clinical Stage, Medical Research, Life Sciences, Pharmaceutical Services, Biotechnology, Healthcare Research, Contract Research Organization, Global Healthcare, Drug Manufacturing |
| Competitors | Medtronic, Abbott, Boston Scientific, Stryker, Zimmer Biomet, Johnson & Johnson, B. Braun Group, Terumo, Cardinal Health, Smith+Nephew +45 more (view full list) |
Looking for a particular VivaMed employee's phone or email?
Kendric Speagle is the CEO of VivaMed.
14 people are employed at VivaMed.
VivaMed is based in New York, New York.